Core Viewpoint - First Solar's stock experienced a significant decline of nearly 20% following disappointing guidance for 2026, despite a strong performance in 2023 with a 24% increase in sales to $5.2 billion [1][2]. Group 1: Financial Performance - First Solar reported a 24% increase in sales for the fourth quarter, reaching $5.2 billion [1]. - The company announced the commissioning of a new manufacturing facility in Louisiana and plans for a new 3.7 gigawatt solar panel production facility in South Carolina [1]. Group 2: Future Guidance - The guidance for 2026 indicated no expected sales growth and potential revenue decline, which was a significant disappointment for investors [2]. - Analysts had anticipated sales of approximately $6.2 billion for 2026, highlighting the gap between expectations and the company's guidance [2]. Group 3: Market Reaction - Following the guidance announcement, First Solar's stock was down by 15.2% as of 10:41 a.m. ET, reflecting investor concerns [1]. - Despite the recent decline, First Solar's stock remains 35% higher over the past 12 months, indicating a strong performance prior to this news [3].

Company Overview - SolarEdge Technologies, based in Herzliya Pituach, Israel, is a leading provider of optimized inverter solutions, including inverters, power optimizers, and energy management solutions [11] - The company operates in multiple countries, including China, Vietnam, India, Mexico, Australia, Israel, Europe, Korea, and the United States [11] Investment Insights - SolarEdge Technologies is currently rated 3 (Hold) on the Zacks Rank, with a VGM Score of A, indicating strong potential [12] - The company has a Momentum Style Score of A, with shares increasing by 23.7% over the past four weeks [12] - Two analysts have revised their earnings estimates higher for fiscal 2026, with the Zacks Consensus Estimate increasing from $0.00 to $0.17 per share [12] - SolarEdge has an average earnings surprise of +12.7%, suggesting positive performance relative to expectations [12] Conclusion - With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, SolarEdge Technologies is recommended for investors' consideration [13]

Core Insights - Sunrun (RUN) is expected to report a quarterly loss of -$0.08 per share, a decline of 105.7% year-over-year, with revenues projected at $656.91 million, reflecting a 26.7% increase compared to the same period last year [1] Revenue Estimates - Analysts forecast 'Revenue- Customer agreements and incentives' to be $457.58 million, indicating a year-over-year increase of 17.8% [3] - The consensus estimate for 'Revenue- Solar energy systems and product sales' is $194.27 million, suggesting a year-over-year change of 49.5% [4] - The average prediction for 'Revenue- Customer agreements' is $436.39 million, pointing to a 22.1% increase from the previous year [4] - Analysts estimate 'Revenue- Incentives' will reach $42.28 million, indicating a 36.3% increase from the prior-year quarter [4] - 'Revenue- Solar energy systems' is projected to be $63.65 million, reflecting a year-over-year increase of 70.9% [5] - 'Revenue- Products' is expected to reach $77.66 million, indicating a decline of 16.2% from the prior-year quarter [5] Profit and Cost Estimates - 'Gross Profit- Customer Agreements and Incentives' is expected to reach $113.85 million, compared to $95.94 million reported in the same quarter last year [6] - The estimated 'Cost of solar energy systems and product sales' is projected to be $162.64 million [6] - Analysts suggest that 'Cost of customer agreements and incentives' will likely reach $343.73 million [6] Market Performance - Sunrun shares have shown a return of -3% over the past month, compared to a -0.3% change in the Zacks S&P 500 composite [7] - With a Zacks Rank 2 (Buy), Sunrun is expected to outperform the overall market in the near future [7]

Core Insights - The company has undergone a comprehensive rebranding from N2OFF, Inc. to Nexentis Technologies Inc., reflecting its evolution into an innovative data-driven biotech firm focused on mitochondrial biology and precision oncology [1][2][4] - The rebranding is part of a strategic pivot that includes the integration of MitoCareX Bio Ltd., which is now a wholly-owned subsidiary, enhancing the company's drug discovery capabilities [3][6] Company Overview - Nexentis Technologies Inc. is focused on developing a pipeline of first-in-class small-molecule programs targeting mitochondrial SLC25 carriers, with applications in oncology and inflammatory metabolic diseases [3][5] - The company also maintains investments in solar energy assets through a Ready to Build (RTB) business model, which are considered non-core assets [1][3] Strategic Developments - The acquisition of MitoCareX on October 20, 2025, marked a significant shift from cleantech to biotechnology, establishing a foundation for the company's drug discovery strategy [6] - MitoCareX has validated its MITOLINE discovery platform, generating in vitro data that demonstrates anti-tumor activity and potential anti-inflammatory benefits, with markets for these indications projected to exceed $120 billion by 2030 [6] Research and Development Focus - The company is advancing a precision oncology and inflammation pipeline, targeting hard-to-treat resistant cancers and metabolic-inflammatory diseases, with plans for preclinical candidate nominations [6]

Core Insights - The company achieved record module sales of 17.5 GW in 2025, marking a 24% year-over-year increase despite challenges in shipment profiles and regulatory environments [1] - Management emphasized contract certainty in pricing and delivery to maintain customer trust amid changing tariff scenarios and regulatory developments [1] - A disciplined approach to customer contracting led to 2.3 GW of new gross bookings, including 1 GW in the U.S. utility-scale market at an average selling price (ASP) of $0.364 per watt [1] - Operational growth was bolstered by the start of commercial production at the Louisiana factory and plans for new finishing capacity in South Carolina to enhance domestic production [1] - The company is utilizing its thin-film expertise to advance the CURE semiconductor platform and next-generation perovskite programs, targeting superior lifetime energy yield compared to crystalline silicon [1] - Management actively enforced intellectual property rights, including TOPCon patents, to safeguard its technological advantages against foreign manufacturers [1] - Strategic debookings of 8.3 GW occurred mainly due to contract terminations following customer breaches, allowing the company to maintain a high-quality, forward-earning backlog [1]

Core Viewpoint - SunPower Inc. will participate in the 38th Annual Roth Conference on March 23, 2026, at the Ritz Carlton in Dana Point, CA, with attendance by invitation only for ROTH clients [1] Upcoming Conferences - SunPower will also attend the Cantor Fitzgerald Technology & Industrial Growth Conference in New York City on March 11, 2026, and the Canaccord Virtual Sustainability Summit on March 12, 2026 [2][5] Company Overview - SunPower Inc. is a leading residential solar services provider in North America, offering a digital platform and installation services to support customers transitioning to energy-efficient lifestyles [3]

We recently published 10 Stocks Winning the Market. T1 Energy Inc. (NYSE:TE) was one of the best performers on Tuesday. T1 Energy soared by 12.72 percent on Tuesday to finish at $7.09 apiece, as investors appeared to have hunted for bargains amid the company’s 29 percent fall this month. From the $8.33 closing price in end-January, T1 Energy Inc.’s (NYSE:TE) share price has already fallen by as much as 30 percent to $5.91 apiece, following concerns over the immediate termination of its chief accounting o ...

Core Viewpoint - Indian solar equipment manufacturers experienced significant stock declines following the announcement of preliminary countervailing duties on solar imports from India and other Asian countries by the U.S. government, which aims to counteract government subsidies in these regions [1]. Group 1: Stock Performance - Shares of Indian solar manufacturers fell between 4% and 11% on the day of the announcement, with Waaree Energies dropping as much as 15% before recovering slightly to close 11% lower, marking its worst trading session ever [1]. - Premier Energies and Vikram Solar saw declines of up to 14.2% and 7.8%, respectively, before also recovering some losses [1]. Group 2: U.S. Government Action - The U.S. Commerce Department announced the imposition of countervailing duties on solar cells and panels imported from India, Indonesia, and Laos, with a general subsidy rate of 125.87% determined for solar imports from India [1]. - This trade action is seen as a setback for India's ambitions to strengthen its position in the U.S. solar market, according to analysts and industry representatives [1].

Core Insights - The Trump administration has imposed preliminary duties of 126% on solar imports from India, citing unfair subsidies in manufacturing [1] - Initial levies for Indonesia range from 86% to 143%, while Laos faces a duty of 81% [1] - These tariffs are intended to protect domestic manufacturers but may increase costs for producers and consumers [2] Trade Impact - The new duties differ from previous global tariffs that were recently struck down by the US Supreme Court [3] - India, Indonesia, and Laos accounted for 57% of solar-module imports to the US in the first half of 2025 [3] - Solar imports from India in 2024 were valued at $792.6 million, a significant increase from 2022 [5] Market Dynamics - Chinese solar manufacturers are shifting production to Southeast Asia to maintain access to the US market, but face challenges as those countries also encounter US tariffs [4] - The high levies are expected to limit market access for Indian solar panel manufacturers [6] - The Alliance for American Solar Manufacturing and Trade has called for investigations into subsidies to protect US manufacturing [6] Regulatory Developments - The US International Trade Commission is investigating anti-dumping and countervailing duty claims related to solar imports from the affected countries [5] - A final determination on the investigation is expected by July 6 [7] - The Commerce Department is also conducting an antidumping duty probe of solar cells imported from India, Indonesia, and Laos [7]

Core Insights - First Solar reported record earnings for 2025, with net sales reaching $5.2 billion, a 24% increase in third-party module volumes year-on-year, and projected 2026 sales guidance of up to $5.2 billion, supported by U.S. manufacturing expansion and federal production tax credits [1][5] Financial Performance - Net income for 2025 rose to $1.53 billion, or $14.21 per diluted share, compared to $12.02 per share in 2024, with fourth-quarter earnings at $4.84 per diluted share [2] - Operating income for the year increased to nearly $1.6 billion, while gross profit expanded to $2.12 billion [2] - Adjusted EBITDA for 2025 was $2.36 billion, reflecting adjustments for foreign exchange impacts and other items [4] Cash Position - The company ended 2025 with a gross cash balance of $2.9 billion and a net cash position of $2.4 billion, significantly up from $1.5 billion at the end of the third quarter, driven by tax credit sales and operating cash flow [3] 2026 Guidance - First Solar projects 2026 net sales between $4.9 billion and $5.2 billion, with module volumes expected between 17.0 GW and 18.2 GW, and adjusted EBITDA forecasted at $2.6 billion to $2.8 billion [5] - Capital expenditures are anticipated to be between $800 million and $1.0 billion, with year-end 2026 net cash projected between $1.7 billion and $2.3 billion [5] Gross Margin and Tax Credits - Gross margin guidance for 2026 is set at $2.4 billion to $2.6 billion, factoring in Section 45X tax credits and production start-up expenses [6] - First-quarter 2026 adjusted EBITDA is forecasted at $400 million to $500 million, supported by anticipated tax credit generation of up to $400 million [6] Strategic Developments - 2025 marked a milestone with the commissioning of a new manufacturing plant in Louisiana and plans for an additional facility in South Carolina, reinforcing First Solar's position as the largest U.S.-based photovoltaic manufacturer [8] - The company utilizes a vertically integrated domestic process to produce cadmium telluride thin-film modules, differentiating itself from competitors reliant on Asian crystalline silicon supply chains [8]